MDR medadvisor limited

0.00%

8.0¢

MedAdvisor off and running, page-94

First 94 Last

Share
Profile

Follow
MellowYellow

1,957 Posts.

125

06/01/16

20:04

Post #: 16742997
Share

Originally posted by mwazowski ↑

Hi Orange7575, sorry for late reply, taking some rest over the holidays

History would suggest that CWH will always do what's in their best interest rather than what's in their patient's best interest, and based on this, I do not foresee MDR in CWH in the near future unless the price of integration was extremely attractive or CWH senses a loss of market share to MDR pharmacies.

There are 3 main messaging platforms at the moment, healthnotes which is used by CWH, memocare and MDR. The advantage of MDR over the others is it's user friendly interface and the integrated features. The other two are essentially just SMS services which still charges a set SMS fee per SMS, whereby MDR uses data to send notifications. I think the SMS services are outdated, patients do not have access to their history or information associated with their treatments.

Having said that though, I think MDR is currently in a quarter of pharmacies in Oz, it's still in the early stages, each pharmacy has yet to saturate their customer database. CWH has roughly 30-35% market share, so MDR still has some room to grow both domestically but also internationally if they play their cards right.

MDR works best in a patient driven health focused community pharmacy, not in a profit and volume driven business like CWH, for starters, they probably would not want to pay the subscription fee and I really can't see a newly registered pharmacist who's getting paid $25 an hour to churn out 400 scripts a day spending any time enrolling customers and maintaining databases. But that's just my opinion, happy to be proven wrong as it would be great for the shareholders.

Expand

Thanks for the detailed reply @mwazowski , it has helped me better understand which sections of the market MDR will have success in. Fully agree with your thought on CWH.

I'm just wondering though do the revenue from MedAdvisor only come from the subscription fee paid by participating pharmacies (and how much they pay) or is there also revenue from customers using the service?
Thanks mate........hope you are enjoying some nice R&R on your holidays!

Last edited by MellowYellow: 06/01/16

MDR Price at posting: 3.8¢ Sentiment: None Disclosure: Not Held
Upvote

0 Great analysis

Reply

Top Stories

NVO

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

PV1

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AL3

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

PIQ

Proteomics notches up as company launches PromarkerD into the US

First 94 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 8.0¢		Change 0.000(0.00%)		Mkt cap ! $49.98M

Open	High	Low	Value	Volume
8.0¢	8.1¢	8.0¢	$39.78K	497.1K

Buyers (Bids)

No.	Vol.	Price($)
3	370000	7.7¢

Sellers (Offers)

Price($)	Vol.	No.
8.8¢	75865	2

View Market Depth

No.	Vol.	Price($)
1	120000	0.077
2	72644	0.076
1	46500	0.075
2	100013	0.074
1	200000	0.073

Price($)	Vol.	No.
0.088	75865	2
0.090	40000	1
0.091	100000	1
0.095	10588	1
0.099	26569	1

Last trade - 15.11pm 20/06/2025 (20 minute delay)

MDR (ASX) Chart

MedAdvisor off and running, page-94

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Proteomics notches up as company launches PromarkerD into the US

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

MedAdvisor off and running, page-94

Top Stories

Novo flags antimony and gold in the Pilbara – but does it need to step back?

Week 25 Wrap: Fed & BoE pause rates ahead of RBA; Santos-ADNOC, Oz tax reforms

HotCopper Highlights for Week 25: 4DS Memory, Meeka & Sprott-citement

ASX Market Open: Stocks slide as Trump tosses up attacking Iran directly | June 20

Friday’s HotCopper trends: Dreadnoughts's drill delight, Galan's beaut raise | June 19

Listen: HotCopper Wire Podcast 014 – Abu Dhabi wants to buy our 'true' oil and gas gem

Hydrogen tanker stock Provaris inks MOU with "K" LINE to provide advice

AML3D opens new facility in Ohio as US Defence strategy bears fruit

Thursday's HotCopper trends: Second Amplia response, Race combo dosing | June 19

Proteomics notches up as company launches PromarkerD into the US

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News